by draivika_incrowd | Dec 31, 1969
InCrowd CEO and President, Daniel S. Fitzgerald, reviews COVID-19 frontline-treating physicians’ frustrations and concerns from recently tracked InCrowd data. Physicians share their worries over disease exposure for themselves and loved one, job security, and...
by draivika_incrowd | Dec 31, 1969
While crediting life science firms that present a strong and transparent approach to biomarkers, 42% say they need more clear and compelling data to expand biomarker orders WATERTOWN MA June 2, 2021—With oncology biomarker testing advances featuring prominently in...
